Verley
Develops functional whey protein ingredients through precision fermentation for food and nutrition manufacturers
€32MSeries A
Role not disclosedA
Alven
Activity from announced rounds
Activity in this selectionFeb 28, 2026 · Feb 1, 2026
Alven is an investment firm whose own news covers Archy’s Series C and which Attention identifies as a returning investor.
Recorded funding activity
Archy combines dental-practice operations and clinical software with AI tools for routine administrative work. Attention develops agents for revenue-team workflows. The recorded history also includes Generare, which produces molecular data for drug development. These company-level events connect Alven’s attribution across distinct business applications.
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $37.7M 1 disclosed · full round size, not this investor’s share